INDV · Company research
Indivior Pharmaceuticals, Inc. (INDV): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 36.13 | $4,683,760,000 | 4461760000.00 | 37.6326530612244898 | — | 0.06272108843537416012 | 13.6552769679300292 | — | 21.0980180180180183 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.